Skip to main content
Willis Maddrey, MD, Gastroenterology, Dallas, TX

WillisCrockerMaddreyMD

Gastroenterology Dallas, TX

Hepatology & Liver Transplantation

Professor, Internal Medicine, University of Texas Southwestern Medical Center, Southwestern Medical School

Dr. Maddrey is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Maddrey's full profile

Already have an account?

Education & Training

  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1968 - 1970
  • Johns Hopkins University
    Johns Hopkins UniversityResidency, Internal Medicine, 1964 - 1966
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicineClass of 1964
  • Wake Forest University
    Wake Forest UniversityB.S., Summa Cum Laude, 1956 - 1960

Certifications & Licensure

  • TX State Medical License
    TX State Medical License 1991 - 2025
  • PA State Medical License
    PA State Medical License 1982 - 2006
  • MD State Medical License
    MD State Medical License 1970 - 1991
  • American Board of Internal Medicine Internal Medicine

Awards, Honors, & Recognition

  • Henry Strong Denison Scholar in the Medical Sciences
  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
  • Distinguished Alumnus Award The Johns Hopkins University School of Medicine, 2009
  • Join now to see all

Publications & Presentations

PubMed

Journal Articles

  • Efficacy, safety and clinical pharmacology of macitentan in comparison to other endothelin receptor antagonists in the treatment of pulmonary arterial hypertension  
    Dingemanse J1, Sidharta PN, Maddrey WC, Rubin LJ, Mickail H, Expert Opinion On Drug Safety, 1/1/2014
  • Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data  
    CL., Ramond MJ., Naveau S., Maddrey WC., Morgan TRMathurin P., O’Grady J., Carithers RL.,Phillips M., Louvet A., Mendenhall, Gut, 1/1/2011
  • Evaluation of Drug-Induced Serious Hepatotoxicity (eDISH) Application of this Data Organization Approach to Phase III Clinical Trials of Rivaroxaban after Total Hip or...  
    Watkins, P.B., M. Desai, S. D. Berkowitz, G. Peters, Y. Horsmans, D. Larrey, and W. Maddrey, Drug Safety, 1/1/2011
  • Join now to see all

Books/Book Chapters

  • Join now to see all

Lectures

  • 27th Annual New Treatments in Chronic Liver Disease 
    Scripps Conference Services & CME /Scripps Translational Science Institute (STSI), San Diego, Califo - 3/31/2012
  • 40th Annual USC Diagnostic & Therapeutic Skills in Internal Medicine 
    University of Southern California, Maui, Hawaii - 3/12/2012
  • Liver Transplantation 
    Australia - 1/1/1990
  • Join now to see all

Press Mentions

  • Liver Transplant Survivor’s Recovery Linked to Sociodemographic Factors, UTSW Study Shows
    Liver Transplant Survivor’s Recovery Linked to Sociodemographic Factors, UTSW Study ShowsApril 26th, 2023
  • UT Southwestern Nephrologist Addresses National Kidney Foundation
    UT Southwestern Nephrologist Addresses National Kidney FoundationApril 12th, 2023
  • The Origins of the Modern‐Day Study of Drug Hepatotoxicity: Focus on Hyman J. Zimmerman
    The Origins of the Modern‐Day Study of Drug Hepatotoxicity: Focus on Hyman J. ZimmermanMarch 2nd, 2020
  • Join now to see all

Professional Memberships